Detalhe da pesquisa
1.
Three years of maintenance with VRD in multiple myeloma: results of total therapy IIIB with a 15-year follow-up.
Blood Adv
; 8(3): 703-707, 2024 02 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-38052037